0000899243-20-018956.txt : 20200710
0000899243-20-018956.hdr.sgml : 20200710
20200710212157
ACCESSION NUMBER: 0000899243-20-018956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200708
FILED AS OF DATE: 20200710
DATE AS OF CHANGE: 20200710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ignelzi Troy A.
CENTRAL INDEX KEY: 0001579829
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 201024177
MAIL ADDRESS:
STREET 1: C/O ESPERION THERAPEUTICS, INC.
STREET 2: 46701 COMMERCE CENTER DRIVE
CITY: PLYMOUTH
STATE: MI
ZIP: 48170
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 ARCH STREET
STREET 2: SUITE 3110
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 33 ARCH STREET
STREET 2: SUITE 3110
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-08
0
0001771917
Karuna Therapeutics, Inc.
KRTX
0001579829
Ignelzi Troy A.
C/O KARUNA THERAPEUTICS, INC.
33 ARCH ST STE 3110
BOSTON
MA
02110-1424
0
1
0
0
Chief Financial Officer
Common Stock
2020-07-08
4
M
0
6000
9.20
A
6000
D
Common Stock
2020-07-08
4
M
0
2000
9.20
A
8000
D
Common Stock
2020-07-08
4
S
0
6000
98.32
D
2000
D
Common Stock
2020-07-08
4
S
0
2000
100.00
D
0
D
Option (right to buy)
9.20
2020-07-08
4
M
0
6000
0.00
D
2020-03-01
2029-03-21
Common Stock
6000
244794
D
Option (right to buy)
9.20
2020-07-08
4
M
0
2000
0.00
D
2020-03-01
2029-03-21
Common Stock
2000
242794
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
/s/ Troy Ignelzi
2020-07-10